About Excellere

Life sciences consultancy for companies and investors

Strategic clarity for decisions, from scientific development to commercial implementation.

We structure complex challenges and create robust decision-making foundations at management level. Without delegation to junior teams.

Learn more about Excellere

Management

Leadership experience that directly informs decision-making.

Excellere is led by experts with more than 20 years of industry and leadership experience in both industry and consulting. The executive team is actively involved in client engagements and personally oversees key analysis and decision-making processes.

Without delegation to junior teams.

Dr. Rahul Agrawal

Dr. Rahul Agrawal

More than 20 years of experience in clinical development, Medical Affairs, and regulatory classification, with a focus on structuring robust development programs along medical and regulatory decision-making processes.

Most recently, as Chief Medical and Development Officer, responsible for steering clinical programs and integrating clinical evidence, regulatory strategy, and medical positioning into sound development decisions.

Positions at Astra Zeneca, Bayer, Menarini, and Cardior Pharmaceuticals, as well as at Charité Berlin.

Dr. René Munser

More than 20 years of experience in commercial leadership roles, with a focus on building, steering, and scaling sustainable commercial organizations as well as governance and decision-making structures.

Most recently, as Vice President Commercial Operations, responsible for developing integrated commercial models and leading complex organizations through phases of growth and transformation.

Positions at Bayer, Schering, and CytoSorbents, as well as the German Heart Center Foundation.

Mark Thomet

More than 20 years of experience in commercial strategy, business development, and analytical management, with a focus on structuring valuation processes and developing decision-ready business cases for management and investors.

Most recently, as Director of Commercial Strategy & Analytics, responsible for portfolio and valuation decisions as well as translating market, competitive, and financial dynamics into robust decision-making foundations.

Positions at Bayer and Schering.

Advisory Board

Leanly structured. Broadening perspectives. Independent in evaluation.

The advisory board complements the management’s operational work by adding additional expertise and an independent perspective in situations where decisions have far-reaching consequences. It deliberately introduces additional viewpoints when complexity increases, risks rise, and clear decisions are required.

Dr. Gabriele Bräunlich

Regulatory Strategy & Development

Dr. Gabriele Bräunlich

Regulatory Strategy & Development

Structures regulatory strategies and approval processes so that clinical programs become decision-ready and aligned with the expectations of investors, partners, and regulatory authorities.

More than 30 years of experience in the pharmaceutical industry, with a particular focus on Regulatory Affairs across the entire development lifecycle. Most recently, as Vice President Regulatory Affairs, responsible for global approval strategies and interactions with authorities.

Positions at international pharmaceutical companies, as well as extensive experience in managing regulatory aspects of complex development programs.

Translates market and competitive dynamics into robust decision-making foundations for positioning, portfolio, and growth in complex life sciences markets.

Extensive international experience in strategic insights, commercial strategy, and market modeling. Most recently, as Vice President Strategic Insights, responsible for deriving decision-relevant market and competitive framworks.

Managing Director of our partner company Engler Consulting GmbH.

Yvonne Engler

Market & Strategic Insights

Yvonne Engler

Market & Strategic Insights

Dr. Jan Georg Möller

Commercial Strategy & Market Access

Dr. Jan Georg Möller

Commercial Strategy & Market Access

Structures market access strategies and commercial models so that innovations become realistically reimbursable and economically viable.

More than 20 years of experience in market access and commercial strategy, with a focus on global product launches as well as pricing and reimbursement strategies. Most recently served as Vice President Market Access.

Managing Director of our partner company möller & minds GmbH.

Extensive experience in complex legal matters in the pharmaceutical and healthcare sectors, particularly in global distribution, as well as in the research and development of medicinal products and their international approval. Most recently, served as Vice President Legal and Senior Partner.

Comprehensive expertise in the legal support of international development and commercialization programs.

Dr. Steffen Schröder

Legal & Governance

Dr. Steffen Schröder

Legal & Governance

Dr. Gabriele Bräunlich

Regulatory Strategy & Development

Structures regulatory strategies and approval processes so that clinical programs become decision-ready and aligned with the expectations of investors, partners, and regulatory authorities.

Positions at international pharmaceutical companies, as well as extensive experience in managing regulatory aspects of complex development programs.

Translates market and competitive dynamics into robust decision-making foundations for positioning, portfolio, and growth in complex life sciences markets.

Managing Director of our partner company Engler Consulting GmbH.

Yvonne Engler

Market & Strategic Insights

Dr. Jan Georg Möller

Commercial Strategy & Market Access

Structures market access strategies and commercial models so that innovations become realistically reimbursable and economically viable.

Managing Director of our partner company möller & minds GmbH.

Comprehensive expertise in the legal support of international development and commercialization programs.

Dr. Steffen Schröder

Legal & Governance

Testimonial

"We didn’t work with a single consultant, but with a team of experienced specialists who knew exactly which questions mattered."

Founder, Life Science Startup

Consultant Network

Advanced expertise for decisions that require more than one perspective.

Our teams consist of senior management, an advisory board, and specialized experts. All are actively involved in client engagements and contribute their respective perspectives in a structured and deliberate way to decision-making processes.

All experts are directly engaged in client work. No purely advisory role.

The advisory network is brought in selectively where decisions require additional depth or a broader perspective. Instead of isolated viewpoints, an integrated perspective emerges across development, regulatory, financing, commercial strategy, and execution.

How We Work

Structuredcollaborationfordecision-makingunderuncertainty.

We work along clearly defined questions and structure complex situations so that robust decisions can be made. In doing so, we combine strategic perspective with operational execution and bring together the expertise required in each case in a targeted way.

A clearly defined question instead of open-ended analysis.

Every collaboration begins with a precise definition of the decision at hand. We structure content strictly around what is relevant to the decision, rather than around generic analyses.

Senior expertise in execution.

All engagements are led by experienced executives and specialized experts. Analysis, assessment, and implementation take place directly at decision-maker level. Without delegation to junior teams.

Integration instead of handoffs.

We work in an integrated manner across development, regulatory, financing, and commercialization. Instead of isolated workstreams, this creates a consistent decision-making logic that reduces risk and enables execution.

A clearly defined question instead of open-ended analysis.

Every collaboration begins with a precise definition of the decision at hand. We structure content strictly around what is relevant to the decision, rather than around generic analyses.

Senior expertise in execution.

All engagements are led by experienced executives and specialized experts. Analysis, assessment, and implementation take place directly at decision-maker level. Without delegation to junior teams.

Integration instead of handoffs.

Partner Companies

Partnershipsthatdelivertargetedvalue.

We collaborate with selected partner companies when specific questions require additional expertise.

Partner selection is not standardized but situation-specific, guided by a clear focus on the precision and suitability of expertise.

This ensures that additional perspectives are integrated in a targeted way without compromising the clarity of the overall structure.

Funding and research grants.

Auxilo supports the identification, application for, and structured implementation of government funding programs and research grants. The focus is on robust application strategies and efficient administrative execution.

More about Auxilo

CRO for preclinical and clinical immunobiomarkers.

CheckImmune supports the planning, execution, and evaluation of preclinical and clinical immunobiomarker analyses. The focus is on the structured integration of biomarker data to improve decision-making quality and reduce development risks.

More about CheckImmune

Medical Communication.

InterComm International is specialized agency for medical and scientific communication with a clear focus on scientific storytelling. The team translates complex data and mechanisms of action into clear, consistent narratives for relevant stakeholders.

More about InterComm

Commercial strategy and market access.

möller & minds supports market access, pricing, and reimbursement strategies, as well as the evidence-based development of payer-relevant argumentation frameworks.

Learn more about möller & minds

Funding and research grants.

More about Auxilo

CRO for preclinical and clinical immunobiomarkers.

More about CheckImmune

Medical Communication.

More about InterComm

Commercial strategy and market access.

möller & minds supports market access, pricing, and reimbursement strategies, as well as the evidence-based development of payer-relevant argumentation frameworks.

Learn more about möller & minds

Contact

Whenconcretedecisionsarerequired,wediscussthemtogether.

We assess your situation in a structured manner and define which next steps are appropriate, as well as where the key risks and value drivers lie.

Contact

Whenconcretedecisionsarerequired,wediscussthemtogether.

We assess your situation in a structured manner and define which next steps are appropriate, as well as where the key risks and value drivers lie.